As of January 2025, Sinopharm Group has a market cap of $3.79B. This makes Sinopharm Group the world's 3256th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.56B | 0.73% |
2023 | $3.53B | 3.07% |
2022 | $3.43B | 16.98% |
2021 | $2.93B | -9.88% |
2020 | $3.25B | -33.85% |
2019 | $4.91B | -13.53% |
2018 | $5.68B | -2.66% |
2017 | $5.84B | 5.79% |
2016 | $5.52B | 2.73% |
2015 | $5.37B | 13.30% |
2014 | $4.74B | 23.37% |
2013 | $3.84B | -8.25% |
2012 | $4.19B | 29.96% |
2011 | $3.22B | -31.14% |
2010 | $4.68B | -1.63% |
2009 | $4.76B | - |